Beyond Indication Expansion: Aligning Evidence, Reimbursement, and Access in Multi-Indication Oncology Drugs [Letter]
Open
Ahmad Yusroni
2026
Drug Design, Development and Therapy
Vol. 20
Letter
Cited by 0
Abstract
[No abstract available]
Affiliations
Department of Applied Public Administration, Faculty of Vocational Studies, State University of Surabaya, Surabaya, Indonesia
